C50.9
Conditions
Interventions
Group 1: A retrospective study evaluating all female patients who underwent an MRI-guided vacuum-assisted biopsy of the breast between September 2007 and December 2024.
Sponsors
Klinik für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Bonn
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Complete pre-procedural MRI imaging showing the target lesion (BIRADS 3–5). No corresponding finding on conventional imaging. MRI-guided needle biopsy performed. Complete histopathological results of the biopsy. Verification of the biopsy results either through subsequent surgery with histopathological diagnosis or through follow-up examinations
Exclusion criteria
Exclusion criteria: Missing or incomplete pre-intervention MRI, missing clinical or histopathological data. Lack of final verification of the result.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of histopathological results, in particular the proportion of malignant (B5) or high-risk (B3) lesions, the technical success rate, and the frequency of histopathological upgrades over time. The endpoints are assessed following histopathological confirmation (e.g., after biopsy and after resection), as well as during follow-up MRI examinations. The data will be collected via the clinic’s communication system. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints include the impact of MRI-VABB on clinical management, as well as correlations between MRI morphological lesion characteristics and histopathological findings. | — |
Countries
Germany
Contacts
Public ContactAileen Schmidt
Klinik für Diagnostische und Interventionelle Radiologie
Outcome results
None listed